Correlation Between Immunome and Inozyme Pharma
Can any of the company-specific risk be diversified away by investing in both Immunome and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and Inozyme Pharma, you can compare the effects of market volatilities on Immunome and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and Inozyme Pharma.
Diversification Opportunities for Immunome and Inozyme Pharma
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Immunome and Inozyme is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Immunome i.e., Immunome and Inozyme Pharma go up and down completely randomly.
Pair Corralation between Immunome and Inozyme Pharma
Given the investment horizon of 90 days Immunome is expected to generate 1.72 times more return on investment than Inozyme Pharma. However, Immunome is 1.72 times more volatile than Inozyme Pharma. It trades about 0.14 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.56 per unit of risk. If you would invest 1,159 in Immunome on September 2, 2024 and sell it today you would earn a total of 196.00 from holding Immunome or generate 16.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immunome vs. Inozyme Pharma
Performance |
| Timeline |
| Immunome |
| Inozyme Pharma |
Immunome and Inozyme Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immunome and Inozyme Pharma
The main advantage of trading using opposite Immunome and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.| Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |